Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues.

Canadian journal of psychiatry. Revue canadienne de psychiatrie - 1 Dec 2000

Issa A M, Keyserlingk E W

Abstract excerpt

OBJECTIVE: To present some of the ethical concerns pertaining to the anticipated use of apolipoprotein E genotyping in selecting therapy in Alzheimer's disease. METHOD: We review studies that support the utility of apolipoprotein E (APO E) genotyping for predicting drug responsiveness along with the published consensus statements and position papers related to APO E genotyping. Ethical issues pertaining to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to Ethics, Medical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Patient Selection

Share to Pharmacogenetics

Share to Treatment Outcome

Source

Identifiers

PMID: 11190361
DOI: 10.1177/070674370004501007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues.PMID 11190361Read ↗

Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.Semantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical PracticeSemantic proximity Read ↗

Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseSemantic proximity Read ↗

Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.Semantic proximity Read ↗

Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.Semantic proximity Read ↗

The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.Semantic proximity Read ↗

APOE genotyping and response to drug treatment in Alzheimer's disease.Semantic proximity Read ↗

Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.